Immunogenicity for Antisense Oligonucleotides: A Risk-Based Assessment

Bioanalysis - United Kingdom
doi 10.4155/bio-2019-0133
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Science Ltd

Related search

Characterization of Stereoisomerism of Antisense Oligonucleotides.

NIPPON KAGAKU KAISHI
1995English

Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides

Angewandte Chemie
2018English

Synthetic Oligonucleotides: The Development of Antisense Therapeutics

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
1999English

TCPRO: An In-Silico Risk Assessment Tool for Biotherapeutic Protein Immunogenicity

Biophysical Journal
Biophysics
2019English

Targeted Delivery of Antisense Oligonucleotides to Pancreatic Β-Cells

Science advances
Multidisciplinary
2018English

Specific Block of Androgen Receptor Activity by Antisense Oligonucleotides

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2003English

Targeting Translation Termination Machinery With Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations

Nucleic Acid Therapeutics
BiochemistryMolecular MedicineDrug DiscoveryGeneticsMolecular Biology
2019English

Best Minimally Modified Antisense Oligonucleotides According to Cell Nuclease Activity

Antisense and Nucleic Acid Drug Development
2001English

Mechanisms of the Inhibition of Reverse Transcription by Antisense Oligonucleotides.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy